Product Details for NDA 016912
LARODOPA (LEVODOPA)
100MG
Marketing Status: Discontinued
250MG
Marketing Status: Discontinued
500MG
Marketing Status: Discontinued
100MG
Marketing Status: Discontinued
250MG
Marketing Status: Discontinued
500MG
Marketing Status: Discontinued
100MG
Marketing Status: Discontinued
Active Ingredient: LEVODOPA
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LARODOPA (LEVODOPA)
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
250MG
Marketing Status: Discontinued
Active Ingredient: LEVODOPA
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LARODOPA (LEVODOPA)
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG
Marketing Status: Discontinued
Active Ingredient: LEVODOPA
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LARODOPA (LEVODOPA)
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
100MG
Marketing Status: Discontinued
Active Ingredient: LEVODOPA
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LARODOPA (LEVODOPA)
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
250MG
Marketing Status: Discontinued
Active Ingredient: LEVODOPA
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LARODOPA (LEVODOPA)
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG
Marketing Status: Discontinued
Active Ingredient: LEVODOPA
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: LARODOPA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016912
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status: Discontinued
Patent and Exclusivity Information